Physician profile
Sina Bakhshaei
NPI 1285253237
$2,394.14
in general payments reported to CMS, 2019-2025
19 companies · $892 in 2025
The $892 reported for 2025 was more than what 84% of Adolescent Medicine (Internal Medicine) providers received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,502 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977 · Education: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.15 |
| Education | $416.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $499.13 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $456.31 | 2024-2025 | Micra, Symplicity G3, Claria Mri Quad Crt-D Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.29 | 2024-2025 | Lifevest |
| Abbott Laboratories | $251.43 | 2024-2025 | Cardiomems, Aveir, Perclose Prostyle |
| Abiomed | $195.70 | 2024-2025 | Impella |
| Inspire Medical Systems, INC. | $118.61 | 2025 | Inspire |
| Penumbra, INC. | $102.85 | 2024 | Indigo System |
| Biotronik INC. | $102.50 | 2024-2025 | Amvia Edge |
| Terumo Medical Corporation | $62.87 | 2024 | Angio-Seal, Tr Band |
| Cvrx, INC. | $54.00 | 2025 | Barostim Neo System |
| Biosense Webster, INC. | $47.51 | 2025 | Carto 3 |
| Heartflow, INC. | $39.67 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $36.06 | 2025 | Wainua |
| Amgen INC. | $26.00 | 2024 | Repatha |
| Altathera Pharmaceuticals LLC | $25.53 | 2025 | Sotalol Hydrochloride |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $24.49 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Kiniksa Pharmaceuticals International, Plc | $24.16 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $15.72 | 2025 | Nexletol |
| Chiesi USA, INC. | $15.31 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sina Bakhshaei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.